Multidisciplinary Lipid Management for Prevention of Cardiovascular Risks

Recommendations for counseling and managing patients’ lipid levels with newer treatments as prophylaxis against cardiovascular events.

EP. 1: Multidisciplinary Approaches to Reducing CVD Risk

January 14th 2022

The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.

EP. 2: Strategies Used to Treat Hypercholesterolemia

January 14th 2022

The standard of care for managing high cholesterol levels.

EP. 3: Counseling Patients on CVD Risk Factors

January 26th 2022

Recommendations for establishing relationships and talking with patients about primary and secondary prevention against cardiovascular events.

EP. 4: Screening for Cardiovascular Disease

January 26th 2022

Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.

EP. 5: Optimizing Adherence to Therapy for Hypercholesterolemia

February 2nd 2022

Approaches to counseling patients with high cholesterol levels on goals of therapy and the role of lifestyle changes as prevention against cardiovascular events.

EP. 6: Important Considerations When Prescribing Statin Therapy for Hypercholesterolemia

February 2nd 2022

What to know about the efficacy of statin therapies used as cholesterol-lowering therapy.

EP. 7: Statin Add-On Therapy for Hypercholesterolemia

February 9th 2022

The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.

EP. 8: Coverage and Access to Therapies Used to Reduce Cholesterol Levels

February 9th 2022

Opportunities to reduce costs and improve accessibility to therapies used for hypercholesterolemia and prophylaxis against cardiovascular events.

EP. 9: The REDUCE-IT Trial and CVD Prevention

February 16th 2022

An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.

EP. 10: Implications for Prescribing Icosapent Ethyl to Prevent CVD

February 16th 2022

Takeaways of the REDUCE-IT trial of icosapent ethyl as treatment for dyslipidemia and hypertriglyceridemia.